Alex Storozum is a corporate associate whose practice focuses on mergers and acquisitions, private equity transactions, complex debt-and-equity restructurings, commercial contractual transactions, and generally advising corporate clients at various stages in their life-cycles. Alex has represented private equity sponsors, strategic companies, investment managers, lenders, and portfolio companies in transactions across a wide range of sectors, including technology, healthcare, investment advisory, manufacturing, and commercial real estate.

Alex has experience advising on all phases of the deal lifecycle, including structuring, due diligence, drafting and negotiating definitive and ancillary documentation, coordinating regulatory and cross-border issues, coordinating various aspects of auction processes, and overseeing post-closing governance and integration matters. He frequently counsels clients regarding organizational structuring, equity arrangements, and co-investor relationships.

Prior to joining Wilk Auslander, Alex practiced in Latham & Watkins' M&A practice group. In his private equity practice, Alex has advised and counseled clients on acquisitions and dispositions ranging from middle-market transactions to multibillion-dollar deals. His experience includes advising on sponsor-led acquisitions, take-privates, minority and secondary sales among co-investors, and competitive auction processes involving domestic and international bidders. Alex also has restructuring experience, including representing lenders and private equity sponsors in distressed acquisitions and forbearance matters. 

• Advised a private equity sponsor on its $1–2 billion acquisition of a safety and protective-equipment services provider;
• Advised a private equity sponsor on a $5-10 billion take-private transaction;
• Advised multiple private equity sponsors on secondary sales involving multiple technology-sector portfolio company shares;
• Represented an investment management company in its acquisition of a registered investment adviser with over $10 billion in assets under management;
• Represented lender in a forbearance and subsequent distressed acquisition of a commercial real estate debtor;
• Represented a private equity sponsor in its acquisition of a distressed company in the healthcare industry;
• Represented a private equity sponsor in its acquisition of an outdoor-products manufacturer;
• Represented a global investment group in its acquisition of a U.S. based consumer-brand portfolio;
• Represented a public pharmaceutical company in its merger with a publicly traded strategic acquirer;
• Represented a private equity sponsor in its sale of an electronic-communications and defense-technology manufacturer to another private equity company; and
• Represented numerous portfolio companies in their day-to-day operational requirements, including with respect to the administration of incentive equity programs, compliance with applicable laws governing the organization and administration of corporations, LLCs, and various types of partnerships, and complying with the applicable contracts governing their relationships with customers, suppliers, co-investors and JV partners, and other strategic counterparties.